Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.84 -0.08 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.92 | 52 Week High | $8.22 | |||
| Open | $59.72 | 52 Week Low | $3.07 | |||
| Day High | $60.46 | P/E | N/A | |||
| Day Low | $58.82 | EPS | $-1.30 | |||
| Volume | 1,371,520 | |||||
| (NASDAQ: MDGL) | Delayed: 457.96 -9.58 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $467.54 | 52 Week High | $18.24 | |||
| Open | $467.90 | 52 Week Low | $6.60 | |||
| Day High | $481.87 | P/E | N/A | |||
| Day Low | $456.65 | EPS | $0.00 | |||
| Volume | 338,294 | |||||
